A phase II trial of ZD6474 in patients with hereditary metastatic medullary thyroid cancer
Wells, S. ; You, Y. N. ; Lakhani, V. ; Hou, J. ; Langmuir, P. ; Headley, D. ; Skinner, M. ; Morse, M. ; Burch, W. ; Schlumberger, M.
Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.5533-5533 [Periódico revisado por pares]Sem texto completo